Ameriprise Financial Inc Bausch Health Companies Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 10,660 shares of BHC stock, worth $78,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,660

Previous 10,852 1.77%

Holding current value

$78,777

Previous $75,000 14.67%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $1,002 - $1,585	-192 Reduced 1.77%	10,660 $86,000
Q2 2024 Aug 14, 2024	SELL	$6.1 - $10.41 $400,989 - $684,311	-65,736 Reduced 85.83%	10,852 $75,000
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $211,662 - $289,027	-27,241 Reduced 26.24%	76,588 $812,000
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $6,366 - $8,024	975 Added 0.95%	103,829 $832,000
Q3 2023 Nov 14, 2023	SELL	$7.69 - $9.71 $13,319 - $16,817	-1,732 Reduced 1.66%	102,854 $845,000
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $3,935 - $6,054	688 Added 0.66%	104,586 $836,000
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $5,011 - $7,860	-798 Reduced 0.76%	103,898 $841,000
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $2,387 - $3,108	-392 Reduced 0.37%	104,696 $657,000
Q3 2022 Nov 14, 2022	SELL	$4.58 - $9.21 $1,593 - $3,205	-348 Reduced 0.33%	105,088 $723,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $23.63 $121,615 - $407,050	-17,226 Reduced 14.04%	105,436 $881,000
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $1.84 Million - $2.37 Million	85,302 Added 228.32%	122,662 $2.79 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $581,256 - $733,140	25,272 Added 209.07%	37,360 $1.01 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $393,403 - $472,272	-15,711 Reduced 56.52%	12,088 $336,000
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $75,459 - $89,957	2,751 Added 10.98%	27,799 $815,000
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $127,066 - $204,423	5,946 Added 31.13%	25,048 $794,000
Q4 2020 Feb 12, 2021	SELL	$15.31 - $21.12 $136,289 - $188,010	-8,902 Reduced 31.79%	19,102 $403,000
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $6,115 - $8,273	-411 Reduced 1.45%	28,004 $435,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $129,892 - $200,157	9,759 Added 52.31%	28,415 $519,000
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $346,371 - $807,221	-26,685 Reduced 58.85%	18,656 $289,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $102,119 - $172,397	-5,406 Reduced 10.65%	45,341 $1.36 Million
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $24,930 - $30,638	-1,194 Reduced 2.3%	50,747 $1.11 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $182,628 - $235,405	-8,900 Reduced 14.63%	51,941 $1.31 Million
Q1 2019 May 15, 2019	BUY	$20.23 - $26.29 $470,448 - $611,373	23,255 Added 61.87%	60,841 $1.5 Million
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $11,589 - $18,606	657 Added 1.78%	37,586 $694,000
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $762,214 - $947,967	36,929 New	36,929 $948,000

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Bausch Health Companies Inc. Transaction History